On the importance of interpretable machine learning predictions to inform clinical decision making in oncology.

decision-making support high-stakes prediction interpretability and explainability opaque machine learning models precision medicine

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 21 12 2022
accepted: 14 02 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 18 3 2023
Statut: epublish

Résumé

Machine learning-based tools are capable of guiding individualized clinical management and decision-making by providing predictions of a patient's future health state. Through their ability to model complex nonlinear relationships, ML algorithms can often outperform traditional statistical prediction approaches, but the use of nonlinear functions can mean that ML techniques may also be less interpretable than traditional statistical methodologies. While there are benefits of intrinsic interpretability, many model-agnostic approaches now exist and can provide insight into the way in which ML systems make decisions. In this paper, we describe how different algorithms can be interpreted and introduce some techniques for interpreting complex nonlinear algorithms.

Identifiants

pubmed: 36925929
doi: 10.3389/fonc.2023.1129380
pmc: PMC10013157
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1129380

Informations de copyright

Copyright © 2023 Lu, Swisher, Chung, Jaffray and Sidey-Gibbons.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet Oncol. 2015 Apr;16(4):e173-80
pubmed: 25846097
Nat Mach Intell. 2019 May;1(5):206-215
pubmed: 35603010
Behav Ther. 2020 Sep;51(5):675-687
pubmed: 32800297
BMC Med. 2019 Oct 29;17(1):195
pubmed: 31665002
Cancer Lett. 2020 Jul 1;481:55-62
pubmed: 32251707
Entropy (Basel). 2020 Dec 25;23(1):
pubmed: 33375658
J Am Coll Surg. 2022 May 1;234(5):918-927
pubmed: 35426406
JCO Clin Cancer Inform. 2020 Sep;4:799-810
pubmed: 32926637
JCO Clin Cancer Inform. 2021 Dec;5:1208-1219
pubmed: 34910588
Comput Struct Biotechnol J. 2020 Aug 28;18:2300-2311
pubmed: 32994889
Ecancermedicalscience. 2020 Jun 30;14:1065
pubmed: 32728381
Artif Intell Med. 2000 Nov;20(3):205-16
pubmed: 10998587
Ann Surg. 2023 Jan 1;277(1):e144-e152
pubmed: 33914464
JAMA Netw Open. 2021 Jul 1;4(7):e2114723
pubmed: 34232304
Stat Methods Med Res. 1995 Sep;4(3):197-217
pubmed: 8548103
BMC Med Res Methodol. 2019 Mar 19;19(1):64
pubmed: 30890124
BMC Med Inform Decis Mak. 2021 Jun 30;21(1):205
pubmed: 34193140
JMIR Med Inform. 2022 Mar 14;10(3):e33182
pubmed: 35285816
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22071-22080
pubmed: 31619572
J Surg Oncol. 2021 Jan;123(1):52-60
pubmed: 32974930
J Mach Learn Res. 2019;20:
pubmed: 34335110
J Bus Econ Stat. 2019;2019:
pubmed: 33132490
Sci Rep. 2022 Jul 8;12(1):11591
pubmed: 35804179
J Med Internet Res. 2019 Jul 10;21(7):e13659
pubmed: 31293245
Sci Rep. 2021 Nov 26;11(1):23017
pubmed: 34837021
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1127-35
pubmed: 26581149
BMC Med Res Methodol. 2022 Nov 1;22(1):282
pubmed: 36319956
Diabetes Ther. 2021 Jul;12(7):2077-2087
pubmed: 34076849
Stud Health Technol Inform. 2020 Jun 16;270:307-311
pubmed: 32570396
JCO Clin Cancer Inform. 2022 Dec;6:e2200073
pubmed: 36480775
JCO Clin Cancer Inform. 2018 Dec;2:1-11
pubmed: 30652575
JCO Clin Cancer Inform. 2020 Jul;4:637-646
pubmed: 32673068
JCO Clin Cancer Inform. 2020 Oct;4:885-894
pubmed: 33058693
Comput Math Methods Med. 2012;2012:876545
pubmed: 23150740
Yearb Med Inform. 2019 Aug;28(1):120-127
pubmed: 31419824
J Med Ethics. 2022 Sep;48(9):581-585
pubmed: 34006600
N Engl J Med. 2021 Jul 15;385(3):283-286
pubmed: 34260843
Cancer Lett. 2016 Nov 1;382(1):110-117
pubmed: 27241666

Auteurs

Sheng-Chieh Lu (SC)

Section of Patient-Centered Analytics, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Christine L Swisher (CL)

The Ronin Project, San Mateo, CA, United States.
The Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, United States.

Caroline Chung (C)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

David Jaffray (D)

Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Chris Sidey-Gibbons (C)

Section of Patient-Centered Analytics, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Classifications MeSH